Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
Enhancer RNA (eRNA) is a type of noncoding RNA transcribed from enhancer regions. Here, the authors investigate the transcriptional landscape of eRNA in cancer, incorporating pharmacogenomic data to identify potential target genes and therapeutic targets.
Guardado en:
Autores principales: | Zhao Zhang, Joo-Hyung Lee, Hang Ruan, Youqiong Ye, Joanna Krakowiak, Qingsong Hu, Yu Xiang, Jing Gong, Bingying Zhou, Li Wang, Chunru Lin, Lixia Diao, Gordon B. Mills, Wenbo Li, Leng Han |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be0580705883405e8211bdfc3cb55317 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sex-associated molecular differences for cancer immunotherapy
por: Youqiong Ye, et al.
Publicado: (2020) - Zeitschrift fu ̈r Erna ̈hrungswissenschaft Journal of nutritional sciences. Journal des sciences de la nutrition.
-
Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture
por: Katla Kristjánsdóttir, et al.
Publicado: (2020) -
A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer
por: Linbang Wang, et al.
Publicado: (2021) -
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Ying Jing, et al.
Publicado: (2020)